Spruce Biosciences ( ($SPRB) ) has issued an announcement. Spruce Biosciences announced the departure of its Chief Medical Officer, Ralph William ...

Sino Biopharmaceutical (HK:1177) has released an update. Sino Biopharmaceutical has announced positive results from its Phase III study of ...

After opening its first facility in Ohio this year, biopharmaceutical processor Amgen has purchased an additional 22 acres ...

ACTUS-101 is under clinical development by Asklepios BioPharmaceutical and currently in Phase II for Pompe Disease.

Vincerx Pharma, Inc. (Nasdaq: VINC), a biopharmaceutical company aspiring to address the unmet medical needs of patients with ...

As the U.S. stock market experiences a mixed performance, with the Dow Jones Industrial Average gaining for its fifth straight session while other indices falter, investors are exploring diverse ...

The passing of Manmohan Singh at 92 is mourned by leaders worldwide. Condoleezza Rice highlighted his pivotal role in ...

BioNJ will host its 32nd Annual Dinner Meeting and Innovation Celebration Feb. 6, 2025, at the Hilton East Brunswick. The ...

Fudan University is central to Shanghai's push to become an AI-powered medical leader. It has established several institutes, ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Gilead Sciences, Inc. (NASDAQ:GILD), a biopharmaceutical company, discovers, develops and commercializes medicines to address ...

Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs ...